ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,408, issued on Dec. 23, was assigned to Minovia Therapeutics Ltd. (Tirat Hacarmel, Israel).
"Mitochondrial augmentation therapy for primary mitochondrial diseases" was invented by Natalie Yivgi Ohana (Haifa, Israel), Uriel Halavee (Tel Aviv, Israel), Shmuel Bukshpan (Ramat Hasharon, Israel), Noa Sher (Haifa, Israel) and Moriya Blumkin (Tel Aviv, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides human stem cells enriched with functional mitochondria, wherein the healthy functional exogenous mitochondria constitute at least 3% and less than 33% of the total mitochondria in the mitochondrially-enriched human stem cell...